Donald E. Bobo Jr.
At a glance: Donald E. Bobo Jr. is Cvp,Strategy/Corp Development at Edwards Lifesciences (EW). Their latest SEC Form 4, filed Nov 9, 2026, reported a sale of $5.0M. On file: 0 purchase lines ($0) and 13 sale lines ($16.2M).
Disclosed holdings: about $12.6M of EW stock: 121,409 shares (including shares held indirectly, e.g. through a trust or fund) reported on their latest Form 4 (filed Nov 9, 2026), valued at the Nov 19, 2026 close of $103.72. This counts only EW shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Cvp,Strategy/Corp Development at Edwards Lifesciences Corp (EW)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Donald E. Bobo Jr.'s InsiderPrint
13 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.
Reading this print: Almost only sells, trading about 13 times a year, typically $818K a trade.
- Bump outward: a purchase (0)
- Dent inward: a sale (13)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Fariborz AssaderaghiSee Remarks · SITM · 99% match
- Kang SunCEO · AMPX · 99% match
- Rajeev SaggarChief Medical Officer · LQDA · 99% match
- Gordon S. LeeChief Accounting Officer · DASH · 99% match
- John P. MullenPresident · GWRE · 99% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 9SEC | EWEdwards Lifesciences Corp | Sell Plan | 48,90022,798 held (−68%) | $103.05 | $5.0M | +0.6% |
| May 27SEC | EWEdwards Lifesciences Corp | Sell | 23,14598,611 held (−19%) | $86.42 | $2.0M | +20.0% |
| May 18SEC | EWEdwards Lifesciences Corp | Sell | 9,96822,798 held (−30%) | $82.07 | $818K | +26.4% |
| May 18SEC | EWEdwards Lifesciences Corp | Sell | 8,00030,970 held (−21%) | $81.82 | $655K | +26.8% |
| Apr 2SEC | EWEdwards Lifesciences Corp | Sell Plan | 4,67639,270 held (−11%) | $80.59 | $377K | +28.7% |
| Apr 2SEC | EWEdwards Lifesciences Corp | Sell Plan | 18,00421,266 held (−46%) | $80.05 | $1.4M | +29.6% |
| Mar 2SEC | EWEdwards Lifesciences Corp | Sell Plan | 11,34021,266 held (−35%) | $85.93 | $974K | +20.7% |
| Feb 26SEC | EWEdwards Lifesciences Corp | Sell | 24,00021,266 held (−53%) | $83.84 | $2.0M | +23.7% |
| Jan 6SEC | EWEdwards Lifesciences Corp | Sell Plan | 2,63240,578 held (−6%) | $84.62 | $223K | +22.6% |
| Jan 6SEC | EWEdwards Lifesciences Corp | Sell Plan | 8,70831,870 held (−21%) | $85.98 | $749K | +20.6% |
| Dec 12SEC | EWEdwards Lifesciences Corp | Sell | 5,48644,870 held (−11%) | $83.79 | $460K | +23.8% |
| Dec 12SEC | EWEdwards Lifesciences Corp | Sell | 5,90038,970 held (−13%) | $83.74 | $494K | +23.9% |
| Dec 10SEC | EWEdwards Lifesciences Corp | Sell Plan | 11,34050,356 held (−18%) | $83.83 | $951K | +23.7% |
- Sell
Cvp,Strategy/Corp Development Donald E Bobo Jr. sold $5.0M of EW at $103.05 — cuts the stake by 68%; pre-scheduled 10b5-1 plan sale.
- Sell
Cvp,Strategy/Corp Development Donald E Bobo Jr. sold $818K of EW at $82.07 — cuts the stake by 30%.
- Sell
Cvp,Strategy/Corp Development Donald E Bobo Jr. sold $377K of EW at $80.59 — pre-scheduled 10b5-1 plan sale.
- Sell
Cvp,Strategy/Corp Development Donald E Bobo Jr. sold $1.4M of EW at $80.05 — cuts the stake by 46%; pre-scheduled 10b5-1 plan sale.
- Sell
Cvp,Strategy/Corp Development Donald E Bobo Jr. sold $974K of EW at $85.93 — cuts the stake by 35%; pre-scheduled 10b5-1 plan sale.
- Sell
Cvp,Strategy/Corp Development Donald E Bobo Jr. sold $2.0M of EW at $83.84 — cuts the stake by 53%.
Follow Donald E. Bobo Jr.
Get one email when Donald E. Bobo Jr. files a new purchase or sale. Free.
At most one email a day about Donald E. Bobo Jr., plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.